Abstract
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All"in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/μL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
Original language | English (US) |
---|---|
Pages (from-to) | 2497-2499 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 71 |
Issue number | 9 |
DOIs | |
State | Published - Nov 1 2020 |
Keywords
- CD4
- HIV
- opportunistic infections
- test-and-treat
- treat all
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases